journal
MENU ▼
Read by QxMD icon Read
search

P & T: a Peer-reviewed Journal for Formulary Management

journal
https://www.readbyqxmd.com/read/27904306/research-briefs
#1
(no author information available yet)
No abstract text is available yet for this article.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904305/minnesota-pharmacists-and-medical-cannabis-a-survey-of-knowledge-concerns-and-interest-prior-to-program-launch
#2
Joy Hwang, Tom Arneson, Wendy St Peter
OBJECTIVES: To assess Minnesota pharmacists' preparedness for the state's medical cannabis program in terms of professional competency in policies and regulations and in pharmacotherapy, as well as their concerns and perceptions about the impact on their practice. The secondary objective was to identify pharmacists' perceptions about ways to reduce potential gaps in knowledge. METHODS: A Web-based 14-item questionnaire was distributed to all pharmacists whose email addresses were registered with the Minnesota Board of Pharmacy...
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904304/the-new-pregnancy-and-lactation-labeling-rule
#3
Sonia Pernia, George DeMaagd
To address the need for updated pregnancy risk categories, the Food and Drug Administration published a final rule in 2014. The authors review the changes the rule makes, its implementation schedule, and its potential clinical impact.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904303/pharmacological-management-and-prevention-of-exacerbations-of-chronic-obstructive-pulmonary-disease-in-hospitalized-patients
#4
Deepali Dixit, Mary Barna Bridgeman, Rani Patel Madduri, Samir T Kumar, Michael J Cawley
Rapid-acting bronchodilators, systemic corticosteroids, and antibiotics are among the keys to managing exacerbations of chronic obstructive pulmonary disease. Preventing exacerbations should also be a component of therapy for the disease.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904302/the-missing-link-evolving-accessibility-to-formulary-related-information
#5
Alison Van Rossum, Megan Holsopple, Julie Karpinski, Jordan Dow
BACKGROUND: Formulary management is a key component to ensuring the safe, effective, and fiscally responsible use of medications for health systems. One challenge in the formulary management process is making the most relevant formulary information easily accessible to practitioners involved in medication therapy decisions at the point of care. In September 2014, Froedtert and the Medical College of Wisconsin (F&MCW) implemented a commercial formulary management tool (CFMT) to improve accessibility to the recently aligned health-system formulary...
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904301/prescription-drug-data-might-help-protect-obamacare-medication-use-will-be-integrated-into-marketplace-plan-risk-adjustments
#6
Stephen Barlas
The Centers for Medicare and Medicaid Services' addition of drug utilization categories to the risk-assessment process aims to make scores more sensitive and accurate, which may help stem the exodus of companies from the marketplace.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904300/perampanel-fycompa-a-review-of-clinical-efficacy-and-safety-in-epilepsy
#7
Jessica Greenwood, Jose Valdes
Perampanel (Fycompa): a review of clinical efficacy and safety in epilepsy.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904299/pharmaceutical-approval-update
#8
Mary Choy
Calcifediol (Rayaldee) for secondary hyperparathyroidism in adults with chronic kidney disease; dasabuvir/ombitasvir/paritaprevir/ritonavir (Viekira XR) for hepatitis C virus infection; and lixisenatide (Adlyxin) for type-2 diabetes.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904298/drug-and-device-news
#9
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904297/the-push-for-additional-orphan-drugs-can-the-fda-do-more-to-encourage-their-development
#10
Stephen Barlas
Can the FDA do more to encourage orphan drug development?
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27904296/using-a-saline-flush-site-unseen-could-lead-to-a-wrong-route-error
#11
Matthew Grissinger
Using a saline flush "site unseen" could lead to a wrong-route error.
November 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27757006/long-term-health-risks-in-childhood-cancer-survivors
#12
(no author information available yet)
No abstract text is available yet for this article.
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27757005/novel-treatments-target-type-2-diabetes
#13
Chris Fellner
Patients with type-2 diabetes can control their blood glucose levels through diet and exercise, by losing excess weight, and by taking medications, such as first-line metformin. We examine several promising drugs in the type-2 diabetes pipeline.
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27757004/european-society-of-cardiology-congress
#14
Walter Alexander
More than 33,000 cardiologists and allied medical professionals gathered in Rome to share the latest cardiac research. We review key sessions from a wide range of therapeutic areas, including anticoagulation, obesity, and hypercholesterolemia.
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27757003/off-label-use-of-dexmedetomidine-for-the-treatment-of-delirium-in-the-intensive-care-unit
#15
Huan Mark Nguyen, Doreen Pon
OBJECTIVE: Evaluate recent clinical studies involving the use of dexmedetomidine (DEX) infusion for the treatment of delirium in the intensive care unit (ICU). METHODS: A literature search was conducted to identify peer-reviewed articles in MEDLINE (1966-June 2016) using the terms sedation, analgesic, dexmedetomidine, delirium, and critically ill adult patients. RESULTS: Two studies in the ICU setting reported the potential benefits of DEX for managing agitation during weaning from mechanical ventilation...
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27757002/therapeutic-interchange-of-clevidipine-for-sodium-nitroprusside-in-cardiac-surgery
#16
Joseph E Cruz, Zachariah Thomas, David Lee, David M Moskowitz, Jeff Nemeth
BACKGROUND: Generic price inflation has resulted in rising acquisition costs for sodium nitroprusside (SNP), an agent historically described as the drug of choice for the treatment of perioperative hypertension in cardiac surgery. PURPOSE: To describe the implementation and cost avoidance achieved by utilizing clevidipine as an alternative to SNP in cardiac surgery patients at a 520-bed community teaching hospital that performs more than 300 cardiac surgeries each year...
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27757001/ptsd-treatment-for-veterans-what-s-working-what-s-new-and-what-s-next
#17
Miriam Reisman
More than a decade of war in the Middle East has pushed post-traumatic stress disorder (PTSD) to the forefront of public health concerns. The author defines the disorder and discusses risk factors, treatments, and the barriers to effective care.
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27757000/mepolizumab-nucala-for-severe-eosinophilic-asthma
#18
Min Sung Choy, Deepali Dixit, Mary Barna Bridgeman
Mepolizumab (Nucala) for severe eosinophilic asthma.
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27756999/pharmaceutical-approval-update
#19
Michele B Kaufman
Obeticholic acid (Ocaliva) for primary biliary cholangitis; sofosbuvir 400 mg/velpatasvir 100 mg (Epclusa) for chronic hepatitis C virus infection; and daclizumab (Zinbryta) for relapsing multiple sclerosis.
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/27756998/drug-and-device-news
#20
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
October 2016: P & T: a Peer-reviewed Journal for Formulary Management
journal
journal
30579
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"